Resistin: A Promising Therapeutic Target for the Management of Type 2 Diabetes Mellitus?

Publisher： Bentham Science Publishers

ISSN： 1567-2697

Source： Drug Design Reviews - Online, Vol.2, Iss.1, 2005-02, pp. : 1-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

DGAT: Novel Therapeutic Target for Obesity and Type 2 Diabetes Mellitus

By  

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 3, Iss. 4, 2003-12 ,pp. : 263-270

Bentham Science Publishers

Access to resources Recommend Favorite

Teglicar "promising tool" in type 2 diabetes mellitus

By  

Inpharma, Vol. 1, Iss. 1655, 2008-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Therapeutic approaches to Type 2 diabetes mellitus

By Rose M.L.   Paulik M.A.   Lenhard J.M.  

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 9, 1999-09 ,pp. : 1223-1236

Informa Healthcare

Access to resources Recommend Favorite

The Role of Sulphonylureas in the Management of Type 2 Diabetes Mellitus

By Rendell M.  

Drugs, Vol. 64, Iss. 12, 2004-01 ,pp. : 1339-1358

Adis International

Access to resources Recommend Favorite

The incretin system in the management of type 2 diabetes mellitus

By Stephens Jeffrey W  

Clinical Medicine, Vol. 10, Iss. 5, 2010-10 ,pp. : 491-495

Royal College Of Physicians

Access to resources Recommend Favorite